Atlas Trials

Zanubrutinib and Acalabrutinib Use and Risk of Atrial Fibrillation in Patients With Chronic B-cell Malignancies

Clinical trial NCT07283965 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07283965
Sponsor
University Hospital, Caen
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Chronic B-cell MalignanciesBTK InhibitorsCardiovascular Diseases
Start date
2025-12-22
Primary completion
2026-01-15
Enrollment
15000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.